Topics

Blue Water Vaccines, developing universal flu vaccine, closes $7 million led by CincyTech

20:00 EDT 8 Jul 2019 | AAAS

(CincyTech) Blue Water Vaccines, a company developing a universal flu vaccine based on technology developed at the University of Oxford, has closed a $7 million seed capital round led by CincyTech. The round was oversubscribed, with additional participation from CincyTech-affiliated private investors. The financing follows a successful preclinical study which offered early validation of the company's novel approach to vaccine design.

Original Article: Blue Water Vaccines, developing universal flu vaccine, closes $7 million led by CincyTech

NEXT ARTICLE

More From BioPortfolio on "Blue Water Vaccines, developing universal flu vaccine, closes $7 million led by CincyTech"

Quick Search

Relevant Topic

Vaccine
A vaccine is a biological preparation that improves immunity to a particular disease. A vaccine typically contains an agent that resembles a disease-causing microorganism, and is often made from weakened or killed forms of the microbe, its toxins or one ...